Loading, Please Wait...
MORRISVILLE, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Tara Fitzgerald, President, Clinical Development Services, and Kari L. Delahunty, Senior Vice President, Corporate Strategy, will be honored by the Healthcare Businesswomen’s Association (HBA). The honorees will be recognized today at the 30th Annual HBA Woman of the Year (WOTY) luncheon in New York City for their leadership within the healthcare industry.
“We’re thrilled to see the industry take notice of Tara and Kari, leaders who exemplify the inclusive and collaborative leadership style that we cultivate at Syneos Health,” said Alistair Macdonald, Chief Executive Officer, Syneos Health. “These honors validate the outstanding results they’ve produced for our biopharmaceutical customers and the impact they’ve had from mentoring their colleagues.”
HBA is a global nonprofit organization comprised of individuals and organizations spanning the healthcare industry committed to furthering the advancement and impact of women in the business of healthcare. Each year, the organization celebrates women leaders across the life sciences and healthcare industry through their “Luminary” and “Rising Star” award program at the WOTY luncheon.
Syneos Health leaders will be recognized this year in both the Luminary and Rising Star categories.
“Our honorees are transforming biopharmaceutical product development while advancing the next generation of talent,” said Lisa van Capelle, Chief Human Resources Officer, Syneos Health. “Tara and Kari’s commitment is aligned with our values of Challenging the Status Quo, Collaborating to Deliver Solutions, and Passionate to Change Patient Lives. They are role models for our people and our purpose.”
Syneos Health has been a member of the HBA for 18 years, supporting employees’ access to local and national professional development, mentoring and career-boosting tools. To further support the development of diverse leaders, the company also launched an internal recognition program in 2017. Modeled after the prestigious HBA awards, the Syneos Health Rising Star and Luminary Awards program has honored more than 60 women worldwide, providing expanded career visibility opportunities and peer-to-peer networking. This year, the program grew to include a Syneos Health Mentor of the Year Award, which honored Mike Menta, President, Syneos Health Consulting, for his dedication to supporting an inclusive work culture.
To further expand the discussion around the importance of women’s leadership in the life sciences industry, the Syneos Health office in London is hosting a live feed of the WOTY luncheon, followed by a panel discussion focused on the power of innovation and creativity in the biopharmaceutical sector.
About Syneos Health
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies, and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com or subscribe to our podcast.
Investor Relations Contact:
Senior Vice President, Investor Relations
+1 919 745 2745
Executive Director, External Communications
+1 202 210 5992